← Leaderboards
Arthur M Mercurio
Children'S Hospital Boston
$23,862,191
Attributed
$24,012,191
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,012,191 · 12
By mechanism
R01$20,815,236 · 9
T32$2,696,955 · 1
R56$300,000 · 1
P30$200,000 · 1
Top collaborators
- Vincent M. Rotello1 shared
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Jordan A. Kreidberg$15,801,451
- Xianhua Piao$12,089,856
- Harvey F Lodish$34,885,272
- Donald E Ingber$21,971,527
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingSignal TransductionCellsTumorIntegrinsBreast CarcinomaVascular Endothelial Growth FactorsMalignant NeoplasmsPropertyNeoplastic CellBaseMalignant Breast NeoplasmNeoplasm MetastasisMammary NeoplasmsCarcinomaGrantRegulationMalignant Epithelial CellIn VivoAutocrineBiologyReceptorBreastTranscription Factor
Grant awards (80)
Mechanisms and Therapy of Radiation Resistance in Breast Cancer$526,484
R01 · FY2025 · CA · contact PI
Novel Therapeutic Approaches for Aggressive Prostate Cancer$383,156
R01 · FY2025 · CA · contact PI
Mechanisms and Therapy of Radiation Resistance in Breast Cancer$512,582
R01 · FY2024 · CA · contact PI
Novel Therapeutic Approaches for Aggressive Prostate Cancer$363,999
R01 · FY2024 · CA · contact PI
Novel Therapeutic Approaches for Aggressive Prostate Cancer$383,156
R01 · FY2023 · CA · contact PI
Integrin Regulation of Non-apoptotic Death in Breast Cancer$375,493
R01 · FY2022 · CA · contact PI
VEGF signaling in Mammary Tumorigenesis$397,813
R01 · FY2021 · CA · contact PI
Integrin Regulation of Non-apoptotic Death in Breast Cancer$383,156
R01 · FY2021 · CA · contact PI
VEGF signaling in Mammary Tumorigenesis$397,813
R01 · FY2020 · CA · contact PI
Integrin Regulation of Non-apoptotic Death in Breast Cancer$383,156
R01 · FY2020 · CA · contact PI
Integrin splicing and cancer stem cell fate$383,156
R01 · FY2020 · CA · contact PI
VEGF signaling in Mammary Tumorigenesis$385,878
R01 · FY2019 · CA · contact PI
Integrin Regulation of Non-apoptotic Death in Breast Cancer$371,660
R01 · FY2019 · CA · contact PI
Integrin splicing and cancer stem cell fate$371,660
R01 · FY2019 · CA · contact PI
VEGF signaling in Mammary Tumorigenesis$397,813
R01 · FY2018 · CA · contact PI
Integrin Regulation of Non-apoptotic Death in Breast Cancer$383,156
R01 · FY2018 · CA · contact PI
Integrin splicing and cancer stem cell fate$383,156
R01 · FY2018 · CA · contact PI
Translational Cancer Biology Training Grant$329,132
T32 · FY2018 · CA · contact PI
VEGF signaling in Mammary Tumorigenesis$397,813
R01 · FY2017 · CA · contact PI
Integrin splicing and cancer stem cell fate$383,156
R01 · FY2017 · CA · contact PI
Translational Cancer Biology Training Grant$315,356
T32 · FY2017 · CA · contact PI
Nanosensor-Based Phenotypic Screening for Precision Therapy of Cancer Stem Cells$300,000
R56 · FY2017 · CA
Integrin splicing and cancer stem cell fate$383,156
R01 · FY2016 · CA · contact PI
VEGF Signaling in Mammary Tumorigenesis$347,563
R01 · FY2016 · CA · contact PI
Mechanisms of Carcinoma Differentiation and Invasion$347,563
R01 · FY2016 · CA · contact PI
Translational Cancer Biology Training Grant$305,307
T32 · FY2016 · CA · contact PI
VEGF Signaling in Mammary Tumorigenesis$347,563
R01 · FY2015 · CA · contact PI
Mechanisms of Carcinoma Differentiation and Invasion$347,563
R01 · FY2015 · CA · contact PI
Translational Cancer Biology Training Grant$240,794
T32 · FY2015 · CA · contact PI
VEGF Signaling in Mammary Tumorigenesis$336,800
R01 · FY2014 · CA · contact PI
Mechanisms of Carcinoma Differentiation and Invasion$336,800
R01 · FY2014 · CA · contact PI
Translational Cancer Biology Training Grant$254,226
T32 · FY2014 · CA · contact PI
VEGF Signaling in Mammary Tumorigenesis$324,596
R01 · FY2013 · CA · contact PI
Mechanisms of Carcinoma Differentiation and Invasion$324,596
R01 · FY2013 · CA · contact PI
VEGF Signaling in Mammary Tumorigenesis$344,450
R01 · FY2012 · CA · contact PI
Mechanisms of Carcinoma Differentiation and Invasion$344,450
R01 · FY2012 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$325,585
R01 · FY2012 · CA · contact PI
Translational Cancer Biology Training Program$230,447
T32 · FY2012 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$103,760
R01 · FY2012 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$325,585
R01 · FY2011 · CA · contact PI
Translational Cancer Biology Training Program$236,434
T32 · FY2011 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$103,760
R01 · FY2011 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$335,655
R01 · FY2010 · CA · contact PI
Mechanisms of Breast Carcinoma Survival$293,995
R01 · FY2010 · CA · contact PI
Translational Cancer Biology Training Program$225,295
T32 · FY2010 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$63,560
R01 · FY2010 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$335,655
R01 · FY2009 · CA · contact PI
Mechanisms of Breast Carcinoma Survival$293,995
R01 · FY2009 · CA · contact PI
Translational Cancer Biology Training Program$278,035
T32 · FY2009 · CA · contact PI
Translational Cancer Biology Training Program$15,604
T32 · FY2009 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$335,655
R01 · FY2008 · CA · contact PI
Mechanisms of Breast Carcinoma Survival$293,995
R01 · FY2008 · CA · contact PI
Epithelial Mesenchymal Transition and Invasive Carcinoma$284,277
R01 · FY2008 · CA · contact PI
Translational Cancer Biology Training Program$266,325
T32 · FY2008 · CA · contact PI
Mechanisms of Breast Carcinoma Survival$99,572
R01 · FY2008 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$325,879
R01 · FY2007 · CA · contact PI
Mechanisms of Breast Carcinoma Survival$293,995
R01 · FY2007 · CA · contact PI
Epithelial Mesenchymal Transition and Invasive Carcinoma$284,277
R01 · FY2007 · CA · contact PI
Mechanisms of Breast Carcinoma Survival$97,146
R01 · FY2007 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$335,440
R01 · FY2006 · CA · contact PI
Mechanisms of Breast Carcinoma Survival$302,387
R01 · FY2006 · CA · contact PI
Epithelial Mesenchymal Transition and Invasive Carcinoma$292,617
R01 · FY2006 · CA · contact PI
Mechanisms of Breast Carcinoma Survival$55,520
R01 · FY2006 · CA · contact PI
Integrin Function and Signaling in Carcinoma Progression$342,630
R01 · FY2005 · CA
MECHANISMS OF BREAST CARCINOMA SURVIVAL$308,003
R01 · FY2005 · CA
Epithelial Mesenchymal Transition and Invasive Carcinoma$298,890
R01 · FY2005 · CA
Integrin Function and Signaling in Carcinoma Progression$359,550
R01 · FY2004 · CA
MECHANISMS OF BREAST CARCINOMA SURVIVAL$323,213
R01 · FY2004 · CA
Epithelial Mesenchymal Transition and Invasive Carcinoma$313,650
R01 · FY2004 · CA
Integrin Function and Signaling in Carcinoma Progression$359,550
R01 · FY2003 · CA
MECHANISMS OF BREAST CARCINOMA SURVIVAL$323,213
R01 · FY2003 · CA
MECHANISMS OF BREAST CARCINOMA SURVIVAL$323,213
R01 · FY2002 · CA
INTEGRIN FUNCTION AND SIGNALING IN CARCINOMA PROGRESSION$311,390
R01 · FY2002 · CA
PILOT AND FEASIBILITY STUDIES$0
P30 · FY2002 · DK
INTEGRIN FUNCTION AND SIGNALING IN CARCINOMA PROGRESSION$360,770
R01 · FY2001 · CA
MECHANISMS OF BREAST CARCINOMA SURVIVAL$323,213
R01 · FY2001 · CA
PILOT AND FEASIBILITY STUDIES$0
P30 · FY2001 · DK
PILOT AND FEASIBILITY STUDIES$0
P30 · FY2001 · DK
INTEGRIN FUNCTION AND SIGNALING IN CARCINOMA PROGRESSION$336,285
R01 · FY2000 · CA
PILOT AND FEASIBILITY STUDIES$200,000
P30 · FY2000 · DK